еНаука - преглед
Преглед према Аутор Reinisch, Walter
Приказ резултата 1 до 17 од 17
| Година | Наслов | Аутор(и) | Тип резултата | Мп-кат. |
|---|---|---|---|---|
| 2014 | Assessment of Fecal Markers and Clinical Outcomes in Patients With Moderately to Severely Active Ulcerative Colitis: Results from PURSUIT-SC Induction | Sandborn, William J; Feagan, Brian G; Marano, Colleen W; Strauss, Richard S; Johanns, Jewel; Zhang, Hongyan; Colombel, Jean-Frederic; Reinisch, Walter; Gibson, Peter R; Collins, Judith;
Tarabar, Dino K; Hebzda, Zbigniew; Rutgeerts, Paul;
| Конференцијски рад | Мп категорија ће бити приказана накнадно. |
| 2019 | Biomarker and pharmacokinetic data from the TURANDOT II open-label extension study of the anti-mucosal addressin cell adhesion molecule-1 (MAdCAM-1) antibody SHP647 in patients with ulcerative colitis | Reinisch, Walter; ...; Tarabar, Dino K; ...; (broj, koautora 17) | Конференцијски рад | Мп категорија ће бити приказана накнадно. |
| 2014 | Clinical Outcomes in Continuous Clinical Responders with Moderately to Severely Active Ulcerative Colitis: Subanalyses from the PURSUIT-SC Maintenance Study | Sandborn, William J; Colombel, Jean-Frederic; Reinisch, Walter; Gibson, Peter R; Feagan, Brian G; Marano, Colleen W; Strauss, Richard S; Johanns, Jewel; Zhang, Hongyan; Weng, Haoling;
Yao, Ruji; Tarabar, Dino K; Hebzda, Zbigniew; Rutgeerts, Paul;
| Конференцијски рад | Мп категорија ће бити приказана накнадно. |
| 2020 | Cobitolimod for Moderate-to-Severe Left-Sided Ulcerative Colitis (CONDUCT): A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Trial | Atreya, Raja; Peyrin-Biroulet, Laurent; Klymenko, Andrii; Augustyn, Monica; Bakulin, Igor; Slankamenac, Dusan S; Miheller, Pal; Gasbarrini, Antonio; Hebuterne, Xavier; Arnesson, Karin;
Knittel, Thomas; Kowalski, Jan; Neurath, Markus F; Sandborn, William J; Reinisch, Walter;
| Конференцијски рад | Мп категорија ће бити приказана накнадно. |
| 2020 | Cobitolimod for moderate-to-severe, left-sided ulcerative colitis (CONDUCT): a phase 2b randomised, double-blind, placebo-controlled, dose-ranging induction trial | Atreya, Raja; Peyrin-Biroulet, Laurent; Klymenko, Andrii; Augustyn, Monica; Bakulin, Igor; Slankamenac, Dusan S; Miheller, Pal; Gasbarrini, Antonio; Hebuterne, Xavier; Arnesson, Karin;
Knittel, Thomas; Kowalski, Jan; Neurath, Markus F; Sandborn, William J; Reinisch, Walter;
| Научни чланак | 21aM21a - Рад у међ. часопису изузетних вредности |
| 2019 | Continuous Clinical Response Is Associated With a Change of Disease Course in Patients With Moderate to Severe Ulcerative Colitis Treated With Golimumab | Reinisch, Walter; Colombel, Jean-Frederic; Gibson, Peter R; Rutgeerts, Paul; Sandborn, William J; Tarabar, Dino K; Huyck, Susan; Khalifa, Ahmed; Marano, Colleen W; Philip, George;
Yao, Ruji; Zhang, Hongyan; Cornillie, Freddy;
| Научни чланак | 21M21 - Рад у врхунском међ. часопису |
| 2016 | Delayed response to golimumab therapy: UC patient characteristics and long-term clinical outcome-post-hoc analyses from the PURSUIT programme | Colombel, J-F; Reinisch, Walter; Gibson, Peter R; Sandborn, William J; Feagan, Brian G; Xu, S; Strauss, Richard S; Zhang, H; Tarabar, Dino K; Hebzda, Z;
Rutgeerts, Paul; Marano, Colleen W;
| Конференцијски рад | Мп категорија ће бити приказана накнадно. |
| 2019 | Efficacy of the anti-mucosal addressin cell adhesion molecule-1 (MAdCAM-1) antibody SHP647 in ulcerative colitis: results from the open-label extension study TURANDOT II | Reinisch, Walter; ...; Tarabar, Dino K; ...; (broj, koautora 17) | Конференцијски рад | Мп категорија ће бити приказана накнадно. |
| 2015 | Fecal Lactoferrin (fLac) and Calprotectin (fCal) as Surrogate Markers of Mucosal Healing: Post-hoc Analysis from the PURSUIT SC Induction Study | Reinisch, Walter; Sandborn, William J; Feagan, Brian G; Rutgeerts, Paul; Gibson, Peter R; Collins, Judith; Tarabar, Dino K; Hebzda, Zbigniew; Colombel, Jean-Frederic; Marano, Colleen W;
Strauss, Richard S; Johanns, Jewel; Zhang, Hongyan;
| Конференцијски рад | Мп категорија ће бити приказана накнадно. |
| 2018 | Long-Term Benefit of Golimumab for Patients with Moderately to Severely Active Ulcerative Colitis: Results from the PURSUIT-Maintenance Extension | Reinisch, Walter; Gibson, Peter R; Sandborn, William J; Feagan, Brian G; Strauss, Richard S; Johanns, Jewel; Padgett, Lakshmi; Adedokun, Omoniyi J; Colombel, Jean-Frederic; Collins, Judith;
Rutgeerts, Paul; Tarabar, Dino K; Marano, Colleen W;
| Научни чланак | 21aM21a - Рад у међ. часопису изузетних вредности |
| 2018 | Long-term safety and efficacy of the anti-MAdCAM monoclonal antibody SHP647 for the treatment of Crohn's disease: the OPERA II study | D'Haens, Geert R; Reinisch, Walter; Lee, SD; Tarabar, Dino K; Louis, E; Klopocka, M; Klaus, J; Schreiber, S; Park, DI; Hebuterne, Xavier;
Cataldi, F; Banerjee, A; Gorelick, K; Sandborn, William J;
| Конференцијски рад | Мп категорија ће бити приказана накнадно. |
| 2021 | Long-term Safety and Efficacy of the Anti-MAdCAM-1 Monoclonal Antibody Ontamalimab [SHP647] for the Treatment of Ulcerative Colitis: The Open-label Study TURANDOT II | Reinisch, Walter; ...; Tarabar, Dino K; ...; (broj, koautora 18) | Научни чланак | 21M21 - Рад у врхунском међ. часопису |
| 2018 | Long-Term Safety of the Anti-Mucosal Addressin Cell Adhesion Molecule-1 (MAdCAM-1) Antibody SHP647 in Ulcerative Colitis: An Open-Label Extension Study (TURANDOT II) | Reinisch, Walter; ...; Tarabar, Dino K; ...; (broj, koautora 17) | Конференцијски рад | Мп категорија ће бити приказана накнадно. |
| 2016 | Maintenance of Efficacy and Continuing Safety of Golimumab for Active Ulcerative Colitis: PURSUIT-SC Maintenance Study Extension Through 1 Year | Gibson, Peter R; Feagan, Brian G; Sandborn, William J; Marano, Colleen W; Strauss, Richard S; Johanns, Jewel; Padgett, Lakshmi; Collins, Judith; Tarabar, Dino K; Hebzda, Zbigniew;
Rutgeerts, Paul; Reinisch, Walter;
| Научни чланак | 21M21 - Рад у врхунском међ. часопису |
| 2016 | Safety, efficacy, and pharmacokinetics of golimumab in patients with moderately to severely Active ulcerative colitis: PURSUIT-SC long-term extension | Reinisch, Walter; Gibson, Peter R; Sandborn, William J; Feagan, Brian G; Marano, Colleen W; Strauss, Richard S; Johanns, Jewel; Zhang, Hongyan; Padgett, Lakshmi; Adedokun, Omoniyi J;
Colombel, J-F; Collins, Judith; Rutgeerts, Paul; Tarabar, Dino K;
| Конференцијски рад | Мп категорија ће бити приказана накнадно. |
| 2016 | Tofacitinib for Induction Therapy in Patients with Active Ulcerative Colitis in Two Phase 3 Clinical Trials: Results by Local and Central Endoscopic Assessments | Feagan, Brian G; Vermeire, Severine; Sandborn, William J; Reinisch, Walter; Tarabar, Dino K; Su, Chinyu; Niezychowski, Wojciech; Zhang, Haiying; Woodworth, Deborah A; Yu, Dahong;
Sands, Bruce E;
| Конференцијски рад | Мп категорија ће бити приказана накнадно. |
| 2017 | Tofacitinib for Maintenance Therapy in Patients With Active Ulcerative Colitis in the Phase 3 OCTAVE Sustain Trial: Results by Local and Central Endoscopic Assessments | Feagan, Brian G; Vermeire, Severine; Sandborn, William J; Reinisch, Walter; Panes, Julian; Tarabar, Dino K; Su, Chinyu; Niezychowski, Wojciech; Zhang, Haiying; Friedman, Gary S;
Woodworth, Deborah A; Sands, Bruce E;
| Конференцијски рад | Мп категорија ће бити приказана накнадно. |